ReviewNature reviews. Urology2012
The effect of ethnicity and sexual preference on prostate-cancer-related quality of life.
Review in Nature reviews. Urology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Impact of Radiation Therapy Dose Escalation on Prostate Cancer Outcomes and Toxicities.American journal of clinical oncology · 2018Pooled it
- Skin CanceR Brachytherapy vs External beam radiation therapy (SCRiBE) meta-analysis.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2018Pooled it
- Hypofractionated radiation therapy for basal and squamous cell skin cancer: A meta-analysis.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2017Pooled it
- Racial/Ethnic Differences in Health-Related Quality of Life Among Gay and Bisexual Prostate Cancer Survivors.Frontiers in oncology · 2022Article
- Understanding Prostate Cancer in Gay, Bisexual, and Other Men Who Have Sex with Men and Transgender Women: A Review of the Literature.Current sexual health reports · 2019Article
- Prostate cancer in sexual minorities and the influence of HIV status.Nature reviews. Urology · 2019Review
- The evolution of brachytherapy for prostate cancer.Nature reviews. Urology · 2017Review
- Men's health supplement use and outcomes in men receiving definitive intensity-modulated radiation therapy for localized prostate cancer.The American journal of clinical nutrition · 2016Article
- Comparison of outcomes and toxicities among radiation therapy treatment options for prostate cancer.Cancer treatment reviews · 2016Review
- A comparison of robotic arm versus gantry linear accelerator stereotactic body radiation therapy for prostate cancer.Research and reports in urology · 2016Review
- Radiation therapy to the primary tumor in locally advanced prostate cancer is not "closing the barn door after the horse has bolted".Annals of translational medicine · 2015Article
- Are HIV-infected men vulnerable to prostate cancer treatment disparities?Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2014Article
- A prostate cancer model build by a novel SVM-ID3 hybrid feature selection method using both genotyping and phenotype data from dbGaP.PloS one · 2014Article
- Evolution of advanced technologies in prostate cancer radiotherapy.Nature reviews. Urology · 2013Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In general, patients with prostate cancer are able to maintain a relatively high quality of life (QOL), commonly reporting improvements in physical, emotional, and social functioning within 1 year of treatment. However, certain subpopulations of patients are susceptible to significant reductions in QOL during the course of their treatment. Data suggest that ethnic background and sexual preference both have significant effects on QOL for patients with prostate cancer. These parameters are often poorly documented and addressed by medical practitioners. Greater attention is needed to identify patients who are at increased risk of QOL reduction as a result of these factors.
Indexed as
Identifiers
22487871What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.